Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes

Leuk Lymphoma. 2019 Dec;60(12):3058-3062. doi: 10.1080/10428194.2019.1617863. Epub 2019 May 23.

Authors

Evan C Chen¹, Lillian Werner², Gabriela S Hobbs³, Rupa Narayan³, Philip C Amrein³, Amir T Fathi³, Andrew M Brunner³

Affiliations

¹ Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
² Biostatistics Core, Dana-Farber Cancer Institute, Boston, MA, USA.
³ Center for Leukemia, Massachusetts General Hospital, Boston, MA, USA.

No abstract available

Publication types

Letter

MeSH terms

Cardiovascular Diseases / etiology*
Genetic Predisposition to Disease*
Humans
Mutation
Myelodysplastic Syndromes / complications*
Myelodysplastic Syndromes / genetics*
Prognosis
Risk Assessment
Risk Factors

Grants and funding